Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Medis Pharma Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (1052)
ARTG (149)
Cancellation or suspension (26)
Listed medicine compliance report (5)
Prescription medicine registration (2)

Date

2024 (866)
2023 (3)
2022 (29)
2021 (106)
2020 (31)
2019 (6)
2018 (6)
2017 (47)
2016 (5)
2015 (29)
2014 (29)
2013 (29)
2012 (23)
2011 (12)
2010 (3)
2009 (8)
2008 (1)
1993 (1)

Results for "[search-keyword]"

Search

Sponsor content

1234 result(s) found, displaying 1151 to 1160

GLIMEPIRIDE ASCENT 3 glimepiride 3 mg tablet blister pack Cancelled under s30(1)(c)

29 June 2017

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
GLIMEPIRIDE ASCENT 4 glimepiride 4 mg tablet blister pack Cancelled under s30(1)(c)

29 June 2017

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
GLIMEPIRIDE-WT 1 glimepiride 1 mg tablet blister pack Cancelled under s30(1)(c)

29 June 2017

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
GLIMEPIRIDE-WT 2 glimepiride 2 mg tablet blister pack Cancelled under s30(1)(c)

29 June 2017

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
GLIMEPIRIDE-WT 3 glimepiride 3 mg tablet blister pack Cancelled under s30(1)(c)

29 June 2017

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
GLIMEPIRIDE-WT 4 glimepiride 4 mg tablet blister pack Cancelled under s30(1)(c)

29 June 2017

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
GLIMEPIRIDE ACCORD 1 glimepiride 1 mg tablet blister pack Cancelled under s30(1)(c)

29 June 2017

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
CARLEVENT levodopa/carbidopa/entacapone 100/25/200 mg tablet bottle (195747)

3 October 2013

ARTG

Australian Register of Therapeutic Goods (ARTG) information for CARLEVENT levodopa/carbidopa/entacapone 100/25/200 mg tablet bottle.
CARLEVENT levodopa/carbidopa/entacapone 125/31.25/200 mg tablet bottle (195748)

3 October 2013

ARTG

Australian Register of Therapeutic Goods (ARTG) information for CARLEVENT levodopa/carbidopa/entacapone 125/31.25/200 mg tablet bottle.
CARLEVENT levodopa/carbidopa/entacapone 150/37.5/200 mg tablet bottle (195749)

3 October 2013

ARTG

Australian Register of Therapeutic Goods (ARTG) information for CARLEVENT levodopa/carbidopa/entacapone 150/37.5/200 mg tablet bottle.

Pages

First page
Previous page
…
Page 112
Page 113
Page 114
Page 115
Current page 116
Page 117
Page 118
Page 119
Page 120
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.